文献速递创伤与烧伤重症综合管理与镇静镇痛消化、代谢与肾脏急症

危重创伤患者早期血浆核DNA、线粒体DNA及核小体浓度与急性肾损伤相关

Early Plasma Nuclear DNA, Mitochondrial DNA, and Nucleosome Concentrations Are Associated With Acute Kidney Injury in Critically Ill Trauma Patients.
PubMed 文献 · Crit Care Explor · 2022-03-28
一句话结论危重创伤患者入院时血浆核DNA升高与后续急性肾损伤独立相关(每log拷贝/μL OR 2.55),核小体与线粒体DNA呈不同动力学。

本研究为前瞻性队列研究,纳入55例需ICU治疗≥24小时的创伤患者,在入院时及6、12、24、48小时采集血浆,按KDIGO肌酐和透析标准定义前6天内的急性肾损伤(AKI)。17例(31%)发生AKI,中位发生时间为入院后12.0小时(IQR 6.2-24.1小时)。入院时核DNA水平与后续AKI显著相关(每log拷贝/μL OR 2.55,95%CI 1.36-4.78,P=0.003),核小体在入院时、24小时和48小时均与AKI相关,线粒体DNA与AKI的关联随时间变化(交互P=0.022),24小时才出现差异。作者认为核DNA在入院时可预测后续AKI,可能成为靶向治疗的切入点。

要点

  • 危重创伤患者入院时血浆核DNA每升高1 log拷贝/μL,后续AKI风险OR 2.55(95%CI 1.36-4.78,P=0.003)。
  • AKI组核DNA在所有时间点均高于非AKI组(总体β=1.41 log拷贝/μL,95%CI 0.86-1.95,P<0.001)。
  • 核小体在入院时(β=0.32,P=0.048)、24小时(β=0.41,P=0.021)、48小时(β=0.71,P<0.001)与AKI相关。
  • 线粒体DNA与AKI的关联随时间变化(交互P=0.022),24小时才出现组间差异(β=0.97 log拷贝/μL,95%CI 0.03-1.90,P=0.043)。
  • 55例创伤患者中17例(31%)发生AKI,中位发生时间为入院后12.0小时(IQR 6.2-24.1小时)。

适用人群与场景

  • 需ICU治疗≥24小时的创伤患者(n=55),来自学术一级创伤中心。

诊断标准与关键阈值

  • AKI定义采用KDIGO血清肌酐和透析标准,评估时间为入院后前6天。

研究设计与关键结果

  • 前瞻性队列研究,55例危重创伤患者,入院时及6、12、24、48小时采集血浆,按KDIGO标准评估前6天AKI。
  • 17例(31%)发生AKI,中位发生时间12.0小时(IQR 6.2-24.1小时)。
  • 线粒体DNA与AKI关联随时间变化(交互P=0.022),24小时出现差异(β=0.97 log拷贝/μL,95%CI 0.03-1.90,P=0.043)。
  • AKI组核DNA所有时间点均较高(总体β=1.41 log拷贝/μL,95%CI 0.86-1.95,P<0.001);入院时核DNA与后续AKI相关(每log拷贝/μL OR 2.55,95%CI 1.36-4.78,P=0.003)。
  • AKI组核小体入院时较高(β=0.32,95%CI 0.00-0.63,P=0.048),24小时(β=0.41,95%CI 0.06-0.76,P=0.021)和48小时(β=0.71,95%CI 0.35-1.08,P<0.001)差异更明显;时间交互P=0.075。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为入院时核DNA可预测后续AKI,可能成为该人群靶向治疗的切入点。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: Circulating nucleic acids, alone and in complex with histones as nucleosomes, have been proposed to link systemic inflammation and coagulation after trauma to acute kidney injury (AKI). We sought to determine the association of circulating nucleic acids measured at multiple time points after trauma with AKI risk.

DESIGN: We conducted a prospective cohort study of trauma patients, collecting plasma on presentation and at 6, 12, 24, and 48 hours, defining AKI over the first 6 days by Kidney Disease Improving Global Outcomes serum creatinine and dialysis criteria. We determined kinetics of plasma mitochondrial DNA (mtDNA), nuclear DNA (nDNA), and nucleosome levels across time points and associations with AKI using multivariable linear mixed-effects models, adjusted for injury characteristics and blood transfusions. We evaluated the association of presentation nucleic acid damage-associated molecular patterns (DAMP) concentrations with subsequent AKI, adjusting for injury severity using multivariable logistic regression.

SETTING: Academic level I trauma center.

PATIENTS: Trauma patients (n = 55) requiring intensive care for greater than or equal to 24 hours after presentation.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: AKI developed in 17 patients (31%), a median of 12.0 hours (interquartile range, 6.2-24.1 hr) after presentation. mtDNA demonstrated a time-varying association with AKI (p = 0.022, interaction with time point), with differences by AKI status not emerging until 24 hours (β = 0.97 [95% CI, 0.03-1.90] log copies/uL; p = 0.043). Patients who developed AKI had higher nDNA across all time points (overall β = 1.41 log copies/uL [0.86-1.95 log copies/uL]; p < 0.001), and presentation levels were significantly associated with subsequent AKI (odds ratio [OR], 2.55 [1.36-4.78] per log copy/uL; p = 0.003). Patients with AKI had higher nucleosome levels at presentation (β = 0.32 [0.00-0.63] arbitrary unit; p = 0.048), a difference that was more pronounced at 24 hours (β = 0.41 [0.06-0.76]; p = 0.021) and 48 hours (β = 0.71 [0.35-1.08]; p < 0.001) (p = 0.075, interaction with time point).

CONCLUSIONS: Plasma nucleic acid DAMPs have distinct kinetics and associations with AKI in critically ill trauma patients. nDNA at presentation predicts subsequent AKI and may be amenable to targeted therapies in this population.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Faust HE, Oniyide O, Wang Y, et al. Early Plasma Nuclear DNA, Mitochondrial DNA, and Nucleosome Concentrations Are Associated With Acute Kidney Injury in Critically Ill Trauma Patients. Crit Care Explor. 2022. PMID: 35372847. doi:10.1097/CCE.0000000000000663

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。